Search research articles
Contact Us
Filters
Showing results (801-810 of 822) with videos related to
Page
of 83
Sort By:
The Lancet. Healthy Longevity
|
February 4, 2024
Behavioural activation to mitigate the psychological impacts of COVID-19 restrictions on older people in England and Wales (BASIL+): a pragmatic randomised controlled trial
Simon Gilbody, Elizabeth Littlewood, Dean McMillan, et al.
European Urology
|
October 19, 2016
Genomic Biomarkers of a Randomized Trial Comparing First-line Everolimus and Sunitinib in Patients with Metastatic Renal Cell Carcinoma
James J Hsieh, David Chen, Patricia I Wang, et al.
JCI Insight
|
June 15, 2017
Genomic landscape and evolution of metastatic chromophobe renal cell carcinoma
Jozefina Casuscelli, Nils Weinhold, Gunes Gundem, et al.
Cancer Immunology Research
|
February 7, 2025
Selective STING Activation in Intratumoral Myeloid Cells via CCR2-Directed Antibody-Drug Conjugate TAK-500
Vicky A Appleman, Atsushi Matsuda, Michelle L Ganno, et al.
Nature Communications
|
June 3, 2020
Two linear epitopes on the SARS-CoV-2 spike protein that elicit neutralising antibodies in COVID-19 patients
Chek Meng Poh, Guillaume Carissimo, Bei Wang, et al.
Biorxiv : the Preprint Server for Biology
|
July 24, 2020
Bivalent binding of a fully human IgG to the SARS-CoV-2 spike proteins reveals mechanisms of potent neutralization
Bei Wang, Daniel Asarnow, Wen-Hsin Lee, et al.
Cell Reports. Medicine
|
January 26, 2021
Sensitive detection of total anti-Spike antibodies and isotype switching in asymptomatic and symptomatic individuals with COVID-19
Yun Shan Goh, Jean-Marc Chavatte, Alicia Lim Jieling, et al.
EMBO Molecular Medicine
|
May 7, 2021
Asymptomatic COVID-19: disease tolerance with efficient anti-viral immunity against SARS-CoV-2
Yi-Hao Chan, Siew-Wai Fong, Chek-Meng Poh, et al.
Clinical & Translational Immunology
|
February 25, 2021
Human neutralising antibodies elicited by SARS-CoV-2 non-D614G variants offer cross-protection against the SARS-CoV-2 D614G variant
Cheryl Yi-Pin Lee, Siti Naqiah Amrun, Rhonda Sin-Ling Chee, et al.
Scientific Reports
|
November 7, 2023
Higher Delta variant-specific neutralizing antibodies prevented infection in close contacts vaccinated with ancestral mRNA vaccines during the SARS-CoV-2 Delta wave
Yun Shan Goh, Siew-Wai Fong, Matthew Zirui Tay, et al.
Page
of 83
Search research articles
Search
Showing results (801-810 of 822) with videos related to
Sort By:
Page
of 83
The Lancet. Healthy Longevity
|
February 4, 2024
Behavioural activation to mitigate the psychological impacts of COVID-19 restrictions on older people in England and Wales (BASIL+): a pragmatic randomised controlled trial
Simon Gilbody, Elizabeth Littlewood, Dean McMillan, et al.
European Urology
|
October 19, 2016
Genomic Biomarkers of a Randomized Trial Comparing First-line Everolimus and Sunitinib in Patients with Metastatic Renal Cell Carcinoma
James J Hsieh, David Chen, Patricia I Wang, et al.
JCI Insight
|
June 15, 2017
Genomic landscape and evolution of metastatic chromophobe renal cell carcinoma
Jozefina Casuscelli, Nils Weinhold, Gunes Gundem, et al.
Cancer Immunology Research
|
February 7, 2025
Selective STING Activation in Intratumoral Myeloid Cells via CCR2-Directed Antibody-Drug Conjugate TAK-500
Vicky A Appleman, Atsushi Matsuda, Michelle L Ganno, et al.
Nature Communications
|
June 3, 2020
Two linear epitopes on the SARS-CoV-2 spike protein that elicit neutralising antibodies in COVID-19 patients
Chek Meng Poh, Guillaume Carissimo, Bei Wang, et al.
Biorxiv : the Preprint Server for Biology
|
July 24, 2020
Bivalent binding of a fully human IgG to the SARS-CoV-2 spike proteins reveals mechanisms of potent neutralization
Bei Wang, Daniel Asarnow, Wen-Hsin Lee, et al.
Cell Reports. Medicine
|
January 26, 2021
Sensitive detection of total anti-Spike antibodies and isotype switching in asymptomatic and symptomatic individuals with COVID-19
Yun Shan Goh, Jean-Marc Chavatte, Alicia Lim Jieling, et al.
EMBO Molecular Medicine
|
May 7, 2021
Asymptomatic COVID-19: disease tolerance with efficient anti-viral immunity against SARS-CoV-2
Yi-Hao Chan, Siew-Wai Fong, Chek-Meng Poh, et al.
Clinical & Translational Immunology
|
February 25, 2021
Human neutralising antibodies elicited by SARS-CoV-2 non-D614G variants offer cross-protection against the SARS-CoV-2 D614G variant
Cheryl Yi-Pin Lee, Siti Naqiah Amrun, Rhonda Sin-Ling Chee, et al.
Scientific Reports
|
November 7, 2023
Higher Delta variant-specific neutralizing antibodies prevented infection in close contacts vaccinated with ancestral mRNA vaccines during the SARS-CoV-2 Delta wave
Yun Shan Goh, Siew-Wai Fong, Matthew Zirui Tay, et al.
Page
of 83